D-830-2013 Class II Terminated

Recalled by Torrent Pharma Inc — Kalamazoo, MI

FDA drug recall D-830-2013 was initiated by Torrent Pharma Inc on Jul 22, 2013 and is designated Class II. Reason for recall: Defective Container; This action is being taken as a precautionary measure due to the product being re-packaged in the U.S. using a filler material that (removes or blocks) less moisture than what is… The recall status is terminated (terminated Jan 31, 2014). Affected quantity: 18,721 bottles.

Recall details

Product Type
Drugs
Report Date
Aug 7, 2013
Initiation Date
Jul 22, 2013
Termination Date
Jan 31, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
18,721 bottles

Product description

Olanzapine Tablets, USP, 10 mg, Rx Only, 30 tablets per bottle, Mfd for: Prasco Laboratories, Mason OH, 45040, USA, Mfd by: Torrent Pharmaceuticals Ltd., Indrad-382 721, Dist. Mehsana India, NDC 66993-463-30

Reason for recall

Defective Container; This action is being taken as a precautionary measure due to the product being re-packaged in the U.S. using a filler material that (removes or blocks) less moisture than what is approved in the application.

Distribution pattern

Nationwide

Code information

Lot #: BS392004A, Exp: 09/2014

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-830-2013
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-830-2013. Report a data issue: hello@regdatalab.com.